11 research outputs found
Burden of genetic risk variants in multiple sclerosis families in the Netherlands
Background: Approximately 20% of multiple sclerosis patients have a family history of multiple sclerosis. Studies of multiple sclerosis aggregation in families are inconclusive. Objective: To investigate the genetic burden based on currently discovered genetic variants for multiple sclerosis risk in patients from Dutch multiple sclerosis multiplex families versus sporadic multiple sclerosis cases, and to study its influence on clinical phenotype and disease prediction. Methods: Our study population consisted of 283 sporadic multiple sclerosis cases, 169 probands from multiplex families and 2028 controls. A weighted genetic risk score based on 102 non-human leukocyte antigen loci and HLA-DRB1*1501 was calculated. Results: The weighted genetic risk score based on all loci was significantly higher in familial than in sporadic cases. The HLA-DRB1*1501 contributed significantly to the difference in genetic burden between the groups. A high weighted genetic risk score was significantly associated with a low age of disease onset in all multiple sclerosis patients, but not in the familial cases separately. The genetic risk score was significantly but modestly better in discriminating familial versus sporadic multiple sclerosis from controls. Conclusion: Familial multiple sclerosis patients are more loaded with the common genetic variants than sporadic cases. The difference is mainly driven by HLA-DRB1*1501. The predictive capacity of genetic loci is poor and unlikely to be useful in clinical settings.</p
Genome-wide significant association with seven novel multiple sclerosis risk loci
Objective: A recent large-scale study in multiple sclerosis (MS) using the ImmunoChip platform reported on 11 loci that showed suggestive genetic association with MS. Additional data in sufficiently sized and independent data sets are needed to assess whether these loci represent genuine MS risk factors.
Methods: The lead SNPs of all 11 loci were genotyped in 10â
796 MS cases and 10â
793 controls from Germany, Spain, France, the Netherlands, Austria and Russia, that were independent from the previously reported cohorts. Association analyses were performed using logistic regression based on an additive model. Summary effect size estimates were calculated using fixed-effect meta-analysis.
Results: Seven of the 11 tested SNPs showed significant association with MS susceptibility in the 21â
589 individuals analysed here. Meta-analysis across our and previously published MS case-control data (total sample size n=101â
683) revealed novel genome-wide significant association with MS susceptibility (p<5Ă10â8) for all seven variants. This included SNPs in or near LOC100506457 (rs1534422, p=4.03Ă10â12), CD28 (rs6435203, p=1.35Ă10â9), LPP (rs4686953, p=3.35Ă10â8), ETS1 (rs3809006, p=7.74Ă10â9), DLEU1 (rs806349, p=8.14Ă10â12), LPIN3 (rs6072343, p=7.16Ă10â12) and IFNGR2 (rs9808753, p=4.40Ă10â10). Cis expression quantitative locus effects were observed in silico for rs6435203 on CD28 and for rs9808753 on several immunologically relevant genes in the IFNGR2 locus.
Conclusions: This study adds seven loci to the list of genuine MS genetic risk factors and further extends the list of established loci shared across autoimmune diseases
Genome-wide significant association with seven novel multiple sclerosis risk loci
Objective: A recent large-scale study in multiple sclerosis (MS) using the ImmunoChip platform reported on 11 loci that showed suggestive genetic association with MS. Additional data in sufficiently sized and independent data sets are needed to assess whether these loci represent genuine MS risk factors.
Methods: The lead SNPs of all 11 loci were genotyped in 10â
796 MS cases and 10â
793 controls from Germany, Spain, France, the Netherlands, Austria and Russia, that were independent from the previously reported cohorts. Association analyses were performed using logistic regression based on an additive model. Summary effect size estimates were calculated using fixed-effect meta-analysis.
Results: Seven of the 11 tested SNPs showed significant association with MS susceptibility in the 21â
589 individuals analysed here. Meta-analysis across our and previously published MS case-control data (total sample size n=101â
683) revealed novel genome-wide significant association with MS susceptibility (p<5Ă10â8) for all seven variants. This included SNPs in or near LOC100506457 (rs1534422, p=4.03Ă10â12), CD28 (rs6435203, p=1.35Ă10â9), LPP (rs4686953, p=3.35Ă10â8), ETS1 (rs3809006, p=7.74Ă10â9), DLEU1 (rs806349, p=8.14Ă10â12), LPIN3 (rs6072343, p=7.16Ă10â12) and IFNGR2 (rs9808753, p=4.40Ă10â10). Cis expression quantitative locus effects were observed in silico for rs6435203 on CD28 and for rs9808753 on several immunologically relevant genes in the IFNGR2 locus.
Conclusions: This study adds seven loci to the list of genuine MS genetic risk factors and further extends the list of established loci shared across autoimmune diseases
Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk
Multiple sclerosis is a complex neurological disease, with 3c20% of risk heritability attributable to common genetic variants, including >230 identified by genome-wide association studies. Multiple strands of evidence suggest that much of the remaining heritability is also due to additive effects of common variants rather than epistasis between these variants or mutations exclusive to individual families. Here, we show in 68,379 cases and controls that up to 5% of this heritability is explained by low-frequency variation in gene coding sequence. We identify four novel genes driving MS risk independently of common-variant signals, highlighting key pathogenic roles for regulatory T cell homeostasis and regulation, IFN\u3b3 biology, and NF\u3baB signaling. As low-frequency variants do not show substantial linkage disequilibrium with other variants, and as coding variants are more interpretable and experimentally tractable than non-coding variation, our discoveries constitute a rich resource for dissecting the pathobiology of MS. In a large multi-cohort study, unexplained heritability for multiple sclerosis is detected in low-frequency coding variants that are missed by GWAS analyses, further underscoring the role of immune genes in MS pathology
MSJ777202_supplementary_data â Supplemental material for Linkage analysis and whole exome sequencing identify a novel candidate gene in a Dutch multiple sclerosis family
<p>Supplemental material, MSJ777202_supplementary_data for Linkage analysis and whole exome
sequencing identify a novel candidate gene in a Dutch multiple sclerosis family by Julia Y
Mescheriakova, Annemieke JMH Verkerk, Najaf Amin, André G Uitterlinden, Cornelia M van
Duijn and Rogier Q Hintzen in Multiple Sclerosis Journal</p